Obstacles greet discount drug plan
Article Abstract:
Reader's Digest and Merck-Medco's discount program for prescription drugs was launched amidst skepticism from patient advocates. The program, which entails an annual membership fee ranging from $25 to $40, entitles consumers to discounts averaging from 11% to 40%. However, several issues threaten to run the program afoul of consumer protection laws. These include state regulations regarding discount card firms and the requirement that discount companies should have a state insurance license.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Prescription drug cost costs jump 10%
Article Abstract:
A study shows that prescription drug prices increased by an average of 9.6% in 1999. The increase in drug prices were attributed to inflation and the introduction of more expensive drugs. The study coincides with calls for greater oversight of the pharmaceutical industry and as Congress considers the inclusion of a prescription drug benefit to Medicare. Total drug expenditures increased 17.% in 1999 while the price of an average prescription was $46.77. With the exclusion of new drugs, the price of prescriptions increased 5.4%.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
New program touts use of generic drugs
Article Abstract:
Generic-drug manufacturers are offering free samples to docttors. The program, called Generics First, will be backed by promotional office visits from pharmacists and support from several large employers including General Motors. The program will be financially backed by generic-drug companies and Merck-Medco, one of the largest pharmacy benefit management companies in the US. The objective of the two-year program is to reach a maximum of 15,000 doctors.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: FTC to debate deal on generic form of Prozac. Cancer drug probe picks up. Credit card firms face Justice suit
- Abstracts: FTC, Intel to square off over interpretation of law. Microsoft's uncertain future rattles investors
- Abstracts: Investors ignore eBay's solid earnings. Impotence treatment wins patent. E-retailers run low on fuel
- Abstracts: Web-wired elevators aim to captivate daily riders. Holiday season blurs at send.com. Can gridlock be cured by expanding airports?